(Q39367170)

11 September 2017

title

Failure of somatostatin to correct manifest diabetic ketoacidosis (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

0 references

K. Lundbaek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

A. P. Hansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

H. Orskov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

S. E. Christensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

J. Iversen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

K. Seyer-Hansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

K. G. Alberti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55530

9 April 2022

R. Whitefoot

8

0 references

language of work or name

English

0 references

publication date

1 January 1976

1 reference

11 September 2017

31 January 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55530

full work available at URL

9 April 2022

https://api.elsevier.com/content/article/PII:S0140673676913386?httpAccept=text/xml

1 reference

10.1016/S0140-6736(76)91338-6

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91338-6

https://api.elsevier.com/content/article/PII:S0140673676913386?httpAccept=text/plain

9 April 2022

1 reference

10.1016/S0140-6736(76)91338-6

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91338-6

9 April 2022

1 reference

11 September 2017

volume

1

1 reference

11 September 2017

issue

7953

1 reference

11 September 2017

page(s)

215-218

1 reference

Role of glucagon and other hormones in development of diabetic ketoacidosis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Diabetic coma: serum growth hormone before and during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

The effect of human growth hormone in hypophysectomized human diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Some Actions of Growth Hormone Release Inhibiting Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Radioimmunological determination of pancreatic and gut glucagon in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

[A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Notes on the Glucose Oxidase Method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Small doses of intramuscular insulin in the treatment of diabetic "coma".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Plasma glucagon and alanine responses to acute insulin deficiency in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Inhibition by somatostatin of ACTH secretion in Nelson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

Editorial: Somatostatin leads to glucagon's renaissance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991338-6

7 January 2021

10.1016/S0140-6736(76)91338-6

Identifiers

DOI

1 reference

11 September 2017

1 reference